Evidence map›Paper›PMID 20418380›Full record

ArticleEukaryotic cell2010

TbPRMT6 is a type I protein arginine methyltransferase that contributes to cytokinesis in Trypanosoma brucei.

John C Fisk, Cecilia Zurita-Lopez, Joyce Sayegh, Danielle L Tomasello, Steven G Clarke, Laurie K Read

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. The Major Protein Arginine Methyltransferase inThe Journal of biological chemistry · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. New insights into the molecular mechanisms of mitosis and cytokinesis in trypanosomes.International review of cell and molecular biology · 2014
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

John C FiskDepartment of Microbiology & Immunology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14214, USA.
Cecilia Zurita-Lopez
Joyce Sayegh
Danielle L Tomasello
Steven G Clarke
Laurie K Read
University at Buffalo, State University of New York · USUniversity of California, Los Angeles · US

Funding

CONTROL OF EUCARYOTIC FUNCTION BY METHYLATIONR37GM026020 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CLARKE, STEVEN G · 2000 to 2009
$5.0M
Protein Arginine Methylation in TrypanosomesR01AI060260 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI READ, LAURIE K. · 2003 to 2014
$3.3M
CONTROL OF EUKARYOTIC MEMBRANE FUNCTION BY METHYLATIONR01GM026020 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CLARKE, STEVEN G · 1985 to 2013
$2.1M
PRMT9, A Novel Protein Arginine MethyltransferaseF31GM078761 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZURITA, CECILIA · 2006 to 2009
$119k
Role of the guide RNA binding protein RBP16 in the bloodstream form of T. bruceiF32AI077185 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI FISK, JOHN C. · 2009 to 2010
$106k
NIAID NIH HHS F32 AI 077185-01NIAID NIH HHS R01 AI 060260NIAID NIH HHS R01 AI060260NIGMS NIH HHS F31 GM078761NIGMS NIH HHS GM 078761NIGMS NIH HHS R01 GM026020NIGMS NIH HHS R37 GM 026020NIGMS NIH HHS R37 GM026020
6 · The paper itself

Abstract

Arginine methylation is a widespread posttranslational modification of proteins catalyzed by a family of protein arginine methyltransferases (PRMTs). In Saccharomyces cerevisiae and mammals, this modification affects multiple cellular processes, such as chromatin remodeling leading to transcriptional regulation, RNA processing, DNA repair, and cell signaling. The protozoan parasite Trypanosoma brucei possesses five putative PRMTs in its genome. This is a large number of PRMTs relative to other unicellular eukaryotes, suggesting an important role for arginine methylation in trypanosomes. Here, we present the in vitro and in vivo characterization of a T. brucei enzyme homologous to human PRMT6, which we term TbPRMT6. Like human PRMT6, TbPRMT6 is a type I PRMT, catalyzing the production of monomethylarginine and asymmetric dimethylarginine residues. In in vitro methylation assays, TbPRMT6 utilizes bovine histones as a substrate, but it does not methylate several T. brucei glycine/arginine-rich proteins. As such, it exhibits a relatively narrow substrate specificity compared to other T. brucei PRMTs. Knockdown of TbPRMT6 in both procyclic form and bloodstream form T. brucei leads to a modest but reproducible effect on parasite growth in culture. Moreover, upon TbPRMT6 depletion, both PF and BF exhibit aberrant morphologies indicating defects in cell division, and these defects differ in the two life cycle stages. Mass spectrometry of TbPRMT6-associated proteins reveals histones, components of the nuclear pore complex, and flagellar proteins that may represent TbPRMT6 substrates contributing to the observed growth and morphological defects.

Indexed as

Amino Acid SequenceCytokinesisGenome, ProtozoanHumansMass SpectrometryMolecular Sequence DataNuclear ProteinsProtein-Arginine N-MethyltransferasesProtozoan ProteinsSequence AlignmentTrypanosoma brucei bruceiNuclear ProteinsPRMT6 protein, humanProtein-Arginine N-MethyltransferasesProtozoan Proteins

Identifiers

PMID20418380
PMCPMC2901642
OpenAlexW2139116984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.